TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14966737

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg/kg) administered for 72 hours, starting within 3 hours after surgery.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no melatonin)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Healthy neonates (group 3)
Number of subjects: 10
Study: 11708689

Group type: EXPERIMENTAL
Intervention: Tri-modal intervention (LEVITY) including brisk 20-minute outdoor walk at target heart rate of 60% of maximum heart rate, increased light exposure, and specific vitamin regimen.
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo vitamin (control group)
Number of subjects: 112
Study: 9455079

Group type: EXPERIMENTAL
Intervention: Thiopental (TPS) 4 mg.kg‐1
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1 MAC)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sevoflurane (2 MAC)
Number of subjects: 38
Study: 7843869

Group type: EXPERIMENTAL
Intervention: Non-contact therapeutic touch (NCTT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mimic practitioners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reiki, LeShan, Intercessory Prayer
Number of subjects: 0
Study: 3285834

Group type: EXPERIMENTAL
Intervention: 100 mg torasemide
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 200 mg torasemide
Number of subjects: 90

Group type: COMPARATOR
Intervention: 100 mg furosemide
Number of subjects: 90

Group type: COMPARATOR
Intervention: 200 mg furosemide
Number of subjects: 90
Study: 30552280

Group type: EXPERIMENTAL
Intervention: Intervention group with free HIV self-testing (HIVST) kits plus site-based HIV testing services.
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group with site-based HIV testing services only.
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Intervention group with free HIVST kits plus site-based HIV testing services.
Number of subjects: 210
Study: 25897147

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 9326

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 9326

Group type: EXPERIMENTAL
Intervention: Pre-frail
Number of subjects: 9326

Group type: EXPERIMENTAL
Intervention: Frail
Number of subjects: 9326

Group type: EXPERIMENTAL
Intervention: Adjusted for baseline characteristics and GRACE covariates
Number of subjects: 9326
Study: 25560051

Group type: EXPERIMENTAL
Intervention: Terbinafine (250 mg once daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Itraconazole (200 mg once daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 23067229

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) for 12 weeks
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) for 12 weeks in OLETF rats
Number of subjects: 76
Study: 20671032

Group type: EXPERIMENTAL
Intervention: Bilateral leg press eccentric exercise
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Unilateral elbow flexor eccentric exercise
Number of subjects: 27
Study: 18520293

Group type: EXPERIMENTAL
Intervention: Sunitinib at 50 mg daily for 4 of 6 weeks
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Sunitinib at 37.5 mg daily (continuous dosing schedule)
Number of subjects: 110
Study: 15496230

Group type: COMPARATOR
Intervention: Serum insulin-like growth factor-1 levels in systemic lupus erythematosus patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serum somatostatin levels in older systemic lupus erythematosus patients (>55 yrs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serum growth hormone levels in systemic lupus erythematosus patients
Number of subjects: 0
Study: 11358918

Group type: EXPERIMENTAL
Intervention: Self-reported performance of MPWs
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: National Malaria Eradication Programme and health education (male MPWs)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Family welfare and immunization programmes (female MPWs)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Key national health programmes (tuberculosis and acute respiratory infection)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Awareness of health problems of the elderly
Number of subjects: 326
Study: 9748012

Group type: EXPERIMENTAL
Intervention: Recombinant human nerve growth factor
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 7833100

Group type: EXPERIMENTAL
Intervention: Scalp hypothermia using Theracool cooling machine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Scalp hypothermia
Number of subjects: 35
Study: 3283804

Group type: EXPERIMENTAL
Intervention: Adinazolam
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31714895

Group type: EXPERIMENTAL
Intervention: L-Citrulline 15 g/d for 2 weeks
Number of subjects: 41
Study: 26757835

Group type: EXPERIMENTAL
Intervention: n-3PUFA with SFA
Number of subjects: 0

Group type: COMPARATOR
Intervention: n-3PUFA with n-6PUFA
Number of subjects: 0
Study: 24451438

Group type: EXPERIMENTAL
Intervention: ICS‐ICT group (n = 77)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Usual care (CPR + UC)
Number of subjects: 154
Study: 22492584

Group type: EXPERIMENTAL
Intervention: Isomaltulose (50 g/day for 12 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sucrose (50 g/day for 12 weeks)
Number of subjects: 110
Study: 20185006

Group type: EXPERIMENTAL
Intervention: Traditional and non-traditional risk factors
Number of subjects: 3675
Study: 18030652

Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 34

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 34
Study: 16236879

Group type: EXPERIMENTAL
Intervention: Single 2.0-g dose of azithromycin microspheres
Number of subjects: 499

Group type: COMPARATOR
Intervention: Extended-release clarithromycin (1.0 g/d for 7 days)
Number of subjects: 499
Study: 11322633

Group type: EXPERIMENTAL
Intervention: 0.5% metoclopramide
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.25% droperidol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 18
Study: 9395150

Group type: EXPERIMENTAL
Intervention: Right unilateral (RUL) ECT
Number of subjects: 39

Group type: COMPARATOR
Intervention: Paroxetine treatment
Number of subjects: 39
Study: 8198976

Group type: EXPERIMENTAL
Intervention: levamisole 2.5 mg kg‐1 day‐1 given for 2 days every week for 18 months
Number of subjects: 78

Group type: COMPARATOR
Intervention: placebo therapy in the same schedule
Number of subjects: 78
Study: 3579807

Group type: EXPERIMENTAL
Intervention: Hypoxic gas mixtures (FIO2 = 17.39%, 14.40%, 11.81%)
Number of subjects: 7
Study: 30630487

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) in Center A
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) in Center B
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control (no DA) in Center A and B
Number of subjects: 107
Study: 27387759

Group type: EXPERIMENTAL
Intervention: 3 months of oral antibiotics
Number of subjects: 107

Group type: COMPARATOR
Intervention: No further antibiotic treatment (control)
Number of subjects: 107
Study: 25234479

Group type: EXPERIMENTAL
Intervention: Increased prefrontal cortex activation in ASD during face recognition task
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: DLPFC activation in ASD
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 31
Study: 24165222

Group type: EXPERIMENTAL
Intervention: Transient elastography (TE) performed by trained nurses using Fibroscan to measure liver stiffness; cutoff score of 6.8 kPa or greater as an indicator of CLD with fibrosis.
Number of subjects: 495
Study: 21792119

Group type: EXPERIMENTAL
Intervention: Tubular diskectomy
Number of subjects: 328

Group type: COMPARATOR
Intervention: Conventional microdiskectomy
Number of subjects: 328
Study: 19196360

Group type: EXPERIMENTAL
Intervention: Amlodipine/valsartan 5/160 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 0
Study: 16924325

Group type: EXPERIMENTAL
Intervention: Bridging plates
Number of subjects: 45

Group type: COMPARATOR
Intervention: Interlocking nails
Number of subjects: 45
Study: 15233977

Group type: EXPERIMENTAL
Intervention: celiprolol
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: carvedilol
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: nebivolol
Number of subjects: 550
Study: 11324774

Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 131

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 131
Study: 9436810

Group type: EXPERIMENTAL
Intervention: Nitroglycerin (NTG)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 8
Study: 8498168

Group type: EXPERIMENTAL
Intervention: Initial oculomotor test
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Follow-up oculomotor test after 15 months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Symptoms in patients with oculomotor dysfunction
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Symptoms in patients with normal test results
Number of subjects: 40
Study: 30786030

Group type: EXPERIMENTAL
Intervention: Provox Luna system
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46
Study: 29966802

Group type: EXPERIMENTAL
Intervention: Mediterranean diet intervention (delivered by dietitians) for 6 months
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Standard-care low-fat diet
Number of subjects: 1032
Study: 26679329

Group type: EXPERIMENTAL
Intervention: KAAA (KEx) supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (CEx) supplementation
Number of subjects: 16
Study: 24976417

Group type: EXPERIMENTAL
Intervention: Purported weight loss supplement (placebo)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Known placebo
Number of subjects: 0
Study: 22551105

Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2.0 to 3.5)
Number of subjects: 2305

Group type: COMPARATOR
Intervention: Aspirin (325 mg per day)
Number of subjects: 2305

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 2305

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 2305
Study: 20345865

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 3229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3229
Study: 18388082

Group type: EXPERIMENTAL
Intervention: Presence of collateral circulation
Number of subjects: 114
Study: 16149737

Group type: EXPERIMENTAL
Intervention: Alpine butter
Number of subjects: 16

Group type: COMPARATOR
Intervention: Margarine
Number of subjects: 16
Study: 12473419

Group type: EXPERIMENTAL
Intervention: Universal drug abuse prevention program
Number of subjects: 758

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 758
Study: 10544864

Group type: EXPERIMENTAL
Intervention: Loperamide HCl 0.5 mg/5 mL
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study: 8669504

Group type: EXPERIMENTAL
Intervention: Telephone condition
Number of subjects: 392

Group type: COMPARATOR
Intervention: Mail condition
Number of subjects: 392
Study: 2003077

Group type: EXPERIMENTAL
Intervention: Lung hyperinflation breaths at tidal volumes of 12cc/kg, 14cc/kg, 16cc/kg, and 18cc/kg of lean body weight followed by suctioning
Number of subjects: 34
Study: 6344540

Group type: EXPERIMENTAL
Intervention: Indomethacin (10(‐5) ‐ 10(‐3) moles/l)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Acetylsalicylic acid, indomethacin, tolfenamic acid (anti-prostaglandins)
Number of subjects: 18
Study: 31042791

Group type: EXPERIMENTAL
Intervention: Increased opacity of CMV retinitis lesions
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Severe opacity (scores 5, 6) in eyes with active disease
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Opacity scoring
Number of subjects: 299
Study: 29696920

Group type: EXPERIMENTAL
Intervention: Combined treatment group (acupuncture + modified formula of buzhong yiqi tang and cizhu wan)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Herbal medicine group (modified formula of buzhong yiqi tang and cizhu wan only)
Number of subjects: 60
Study: 27463259

Group type: EXPERIMENTAL
Intervention: Fried French Fries
Number of subjects: 33

Group type: COMPARATOR
Intervention: Baked Potato
Number of subjects: 33

Group type: COMPARATOR
Intervention: Mashed Potato
Number of subjects: 33

Group type: COMPARATOR
Intervention: Potato Wedges
Number of subjects: 33

Group type: COMPARATOR
Intervention: Pasta Control
Number of subjects: 33
Study: 25261968

Group type: EXPERIMENTAL
Intervention: 12-gene Recurrence Score assay
Number of subjects: 0
Study: 22950660

Group type: EXPERIMENTAL
Intervention: Luteal support with micronized progesterone (P)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Luteal support with progesterone plus 17‐beta‐estradiol (P + E)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No luteal-phase support
Number of subjects: 9
Study: 19631048

Group type: EXPERIMENTAL
Intervention: First Step First Bite Program
Number of subjects: 22

Group type: COMPARATOR
Intervention: First Step Program
Number of subjects: 22
Study: 17211855

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RGZ)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PGZ)
Number of subjects: 17
Study: 15356026

Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO), 45 mg/d for 4 months
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 11250664

Group type: EXPERIMENTAL
Intervention: Low lactose milk powder (twice daily for seven weeks)
Number of subjects: 47

Group type: COMPARATOR
Intervention: No supplement (control group)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Low lactose milk powder
Number of subjects: 47
Study: 9549654

Group type: EXPERIMENTAL
Intervention: (R)-ketoprofen 100 mg
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1,000 mg
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: (R)-ketoprofen 25 mg
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 7989710

Group type: EXPERIMENTAL
Intervention: Immunoprophylaxis (group 2)
Number of subjects: 56

Group type: COMPARATOR
Intervention: No immunoprophylaxis (group 1)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patients with co-existent hepatitis delta virus infection or in group 2
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Recent patients with recurrence
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patients with coexistent delta infection and lower levels of circulating HBV DNA
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Retransplantation for associated graft injury
Number of subjects: 56
Study: 2590265

Group type: EXPERIMENTAL
Intervention: 200 mg ibopamine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Food
Number of subjects: 12
Study: 31922284

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 31200429

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 0
Study: 28027975

Group type: EXPERIMENTAL
Intervention: Robotic simulation curriculum (4 dVSS training tasks: camera clutching 1, suture sponge 1 and 2, and tubes)
Number of subjects: 35

Group type: COMPARATOR
Intervention: No further training (control group)
Number of subjects: 35
Study: 25959323

Group type: EXPERIMENTAL
Intervention: Physical keypad
Number of subjects: 0

Group type: COMPARATOR
Intervention: Touch screen device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Texting with 1 hand/thumb
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased touch screen size
Number of subjects: 0
Study: 23846569

Group type: EXPERIMENTAL
Intervention: Universal screening
Number of subjects: 9572

Group type: COMPARATOR
Intervention: Targeted screening
Number of subjects: 9572
Study: 21851343

Group type: EXPERIMENTAL
Intervention: Stethoscope-guided cuff inflation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard 'just seal' cuff inflation
Number of subjects: 50
Study: 19485584

Group type: EXPERIMENTAL
Intervention: Fluoxetine (antidepressant medication)
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Combination of fluoxetine and cognitive-behavioral therapy
Number of subjects: 332

Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 332
Study: 16825684

Group type: EXPERIMENTAL
Intervention: Meal replacements (2 meal replacements/day, 4904.4 kJ) during an 8-week weight-loss regimen
Number of subjects: 43

Group type: COMPARATOR
Intervention: Carbohydrate restriction (<120 g/d) or fat restriction (<50 g/d) during a 6-month weight-maintenance regimen
Number of subjects: 43
Study: 14615297

Group type: COMPARATOR
Intervention: Normal subjects (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with left posterior cerebral artery infarcts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letter-by-letter reading strategy
Number of subjects: 0
Study: 10809473

Group type: EXPERIMENTAL
Intervention: Education of patients and family members about pain control, monitoring of patients' pain, and feedback about pain with treatment suggestions to nurses and physicians
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 0
Study: 8996575

Group type: EXPERIMENTAL
Intervention: Etoposide phosphate plus cisplatin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Etoposide plus cisplatin
Number of subjects: 120
Study: 1600494

Group type: EXPERIMENTAL
Intervention: Leuprolide + Flutamide
Number of subjects: 603

Group type: COMPARATOR
Intervention: Leuprolide
Number of subjects: 603
Study: 2864793

Group type: EXPERIMENTAL
Intervention: mianserin 30‐60 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: clomipramine 75‐150 mg
Number of subjects: 62
Study: 31986905

Group type: EXPERIMENTAL
Intervention: Volunteering intervention (four 1-hour sessions)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Active control (promoting physical activity)
Number of subjects: 384
Study: 28943384

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 4010

Group type: COMPARATOR
Intervention: Nondiabetic patients
Number of subjects: 4010
Study: 28441966

Group type: EXPERIMENTAL
Intervention: Tegafur-uracil maintenance therapy for 1 year after adjuvant oxaliplatin-based regimen.
Number of subjects: 546

Group type: COMPARATOR
Intervention: Observation arm (no treatment).
Number of subjects: 546
Study: 26333880

Group type: EXPERIMENTAL
Intervention: FM remote microphone system
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 900 MHz remote microphone system
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 2.4 GHz remote microphone system
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Bluetooth paired with near-field magnetic induction remote microphone system
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hearing aids alone
Number of subjects: 16
Study: 24244635

Group type: EXPERIMENTAL
Intervention: HAART+maraviroc
Number of subjects: 97

Group type: COMPARATOR
Intervention: HAART
Number of subjects: 97
Study: 21159787

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 16

Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 16
Study: 18347654

Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg/d for 7-9 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 17009837

Group type: EXPERIMENTAL
Intervention: 40 mg telmisartan
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 80 mg telmisartan
Number of subjects: 36
Study: 12713080

Group type: EXPERIMENTAL
Intervention: 25 mmol/L bicarbonate/10 mmol/L lactate peritoneal dialysis solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: 35 mmol/L lactate solution
Number of subjects: 40
Study: 10669364

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (500 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stavudine-lamivudine
Number of subjects: 0
Study: 9052559

Group type: EXPERIMENTAL
Intervention: Supraceliac aortic clamping (SCC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Infrarenal clamping (IRC)
Number of subjects: 18
Study: 8397839

Group type: EXPERIMENTAL
Intervention: Colgate Precision Full Head soft toothbrush
Number of subjects: 101

Group type: COMPARATOR
Intervention: Crest Complete soft toothbrush
Number of subjects: 101
Study: 3539129

Group type: EXPERIMENTAL
Intervention: Homeopathic drug preparation C (i.v. injections over 5 days)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Homeopathic drug preparation D (i.v. injections over 5 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo control (i.v. injections over 5 days)
Number of subjects: 39
Study: 31608930

Group type: EXPERIMENTAL
Intervention: Ghrelin infusion (1 pmol/min × kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ghrelin infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glucose-dependent insulinotropic polypeptide (positive control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intraluminal glucose
Number of subjects: 8
Study: 29526831

Group type: EXPERIMENTAL
Intervention: Dexketoprofen (50 mg in 100 mL normal saline)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Paracetamol (1 g in 100 mL normal saline)
Number of subjects: 99
Study: 27126852

Group type: EXPERIMENTAL
Intervention: Mental health literacy curriculum integrated into grade 11 and 12 'Healthy Living' courses, delivered by teachers.
Number of subjects: 534

Group type: COMPARATOR
Intervention: Control condition (no intervention).
Number of subjects: 534
Study: 24576912

Group type: EXPERIMENTAL
Intervention: Positive FAST test in EMCC
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Positive FAST test in ambulances
Number of subjects: 900

Group type: COMPARATOR
Intervention: Negative FAST test in EMCC
Number of subjects: 900

Group type: COMPARATOR
Intervention: Negative FAST test in ambulances
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Positive FAST test in nonstroke diagnosis from EMCC
Number of subjects: 900
Study: 22551385

Group type: EXPERIMENTAL
Intervention: Full guided implant surgery (template based guided cavity preparation and guided implant insertion)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Half-guided implant surgery (template based guided cavity preparation and free-handed, manual implant insertion)
Number of subjects: 5